WallStSmart

Heartbeam Inc (BEAT)vsVeeva Systems Inc Class A (VEEV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

VEEV leads profitability with a 28.4% profit margin vs 0.0%. VEEV earns a higher WallStSmart Score of 71/100 (B).

BEAT

Avoid

16

out of 100

Grade: F

Growth: 4.3Profit: 3.0Value: 5.0Quality: 3.3
Piotroski: 2/9Altman Z: -29.68

VEEV

Strong Buy

71

out of 100

Grade: B

Growth: 7.3Profit: 8.0Value: 8.0Quality: 7.8
Piotroski: 4/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BEAT.

VEEVUndervalued (+39.5%)

Margin of Safety

+39.5%

Fair Value

$292.60

Current Price

$172.61

$119.99 discount

UndervaluedFair: $292.60Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BEAT0 strengths · Avg: 0/10

No standout strengths identified

VEEV5 strengths · Avg: 9.0/10
Operating MarginProfitability
30.9%10/10

Strong operational efficiency at 30.9%

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Profit MarginProfitability
28.4%9/10

Keeps 28 of every $100 in revenue as profit

PEG RatioValuation
0.728/10

Growing faster than its price suggests

Revenue GrowthGrowth
16.3%8/10

16.3% revenue growth

Areas to Watch

BEAT4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$48.62M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

VEEV2 concerns · Avg: 3.0/10
P/E RatioValuation
28.2x4/10

Moderate valuation

Free Cash FlowQuality
$02/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : BEAT

BEAT has a balanced fundamental profile.

Bull Case : VEEV

The strongest argument for VEEV centers on Operating Margin, Debt/Equity, Profit Margin. Profitability is solid with margins at 28.4% and operating margin at 30.9%. Revenue growth of 16.3% demonstrates continued momentum.

Bear Case : BEAT

The primary concerns for BEAT are Revenue Growth, EPS Growth, Market Cap.

Bear Case : VEEV

The primary concerns for VEEV are P/E Ratio, Free Cash Flow.

Key Dynamics to Monitor

BEAT profiles as a value stock while VEEV is a growth play — different risk/reward profiles.

VEEV carries more volatility with a beta of 0.95 — expect wider price swings.

VEEV is growing revenue faster at 16.3% — sustainability is the question.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

VEEV scores higher overall (71/100 vs 16/100), backed by strong 28.4% margins and 16.3% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Heartbeam Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

BioTelemetry, Inc., a remote medical technology company, provides remote heart monitoring, remote blood glucose monitoring, centralized central laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research clients throughout the world. The company is headquartered in Malvern, Pennsylvania.

Visit Website →

Veeva Systems Inc Class A

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.

Visit Website →

Want to dig deeper into these stocks?